Giulio Cavalli

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro et al. · The Lancet Rheumatology · 2020 · 991 citations · Full text

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

Eli L. Diamond, Lorenzo Dagna, David M. Hyman et al. · Blood · 2014 · 579 citations · Full text

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis et al. · Nature Medicine · 2021 · 518 citations · Full text

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Corrado Campochiaro, Emanuel Della‐Torre, Giulio Cavalli et al. · European Journal of Internal Medicine · 2020 · 408 citations · Full text

Long Covid, Covid-19 Pandemic, Severe Covid-19 Patients +6

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

Marco Ripa, Laura Galli, Andrea Poli et al. · Clinical Microbiology and Infection · 2020 · 383 citations · Full text

Infectious Disease Epidemiology, Predictive Factors, Healthcare-associated Infection +12